CAS 2170729-29-8

Fórmula: C17H10F3N3O3S2

InChI: InChI=1S/C17H10F3N3O3S2/c18-17(19,20)8-1-2-13-12(3-8)21-14(28-13)5-23-16(26)10-7-27-6-9(10)11(22-23)4-15(24)25/h1-3,6-7H,4-5H2,(H,24,25)

Chave InChI: ORQGHAJIWGGFJK-UHFFFAOYSA-N

SMILES: C1=CC2=C(C=C1C(F)(F)F)N=C(S2)CN3C(=O)C4=CSC=C4C(=N3)CC(=O)O

AT-007

CAS: 2170729-29-8

AT-007

Fórmula: C₁₇H₁₀F₃N₃O₃S₂

Pureza: ≥98%

Peso molecular: 425.4

Ref: 54-BUP02404

AT-007

CAS: 2170729-29-8

AT-007 is an orally active CNS penetrant Aldose Reductase inhibitor for the treatment of Galactosemia (IC50: 100 pM).

Fórmula: C₁₇H₁₀F₃N₃O₃S₂

Pureza: 99.83%

Cor e Forma: Solid

Peso molecular: 425.405

Ref: TM-T10393

2-(4-Oxo-3-((5-(Trifluoromethyl)Benzo[D]Thiazol-2-Yl)Methyl)-3,4-Dihydrothieno[3,4-D]Pyridazin-1-Yl)Acetic Acid

CAS: 2170729-29-8

2-(4-Oxo-3-((5-(Trifluoromethyl)Benzo[D]Thiazol-2-Yl)Methyl)-3,4-Dihydrothieno[3,4-D]Pyridazin-1-Yl)Acetic Acid

Fórmula: C₁₇H₁₀F₃N₃O₃S₂

Pureza: 98%

Peso molecular: 425.4

Ref: 54-PC108452

2-(4-OXO-3-((5-(TRIFLUOROMETHYL)BENZO[D]THIAZOL-2-YL)METHYL)-3,4-DIHYDROTHIENO[3,4-D]PYRIDAZIN-1-YL)ACETIC ACID

CAS: 2170729-29-8

Fórmula: C₁₇H₁₀F₃N₃O₃S₂

Pureza: 98%

Peso molecular: 425.4048

Ref: IN-DA01V487

AT-007

CAS: 2170729-29-8

2-(4-Oxo-3-((5-(trifluoromethyl)benzo[d]thiazol-2-yl)methyl)-3,4-dihydrothieno[3,4-d]pyridazin-1-yl)acetic acid

Fórmula: C₁₇H₁₀F₃N₃O₃S₂

Pureza: 98%

Peso molecular: 425.4

Ref: IN-DG01136164

2-(4-Oxo-3-((5-(trifluoromethyl)benzo[d]thiazol-2-yl)methyl)-3,4-dihydrothieno[3,4-d]pyridazin-1-yl)acetic acid

CAS: 2170729-29-8

Fórmula: C₁₇H₁₀F₃N₃O₃S₂

Pureza: 98%

Peso molecular: 425.4

Ref: 10-F546907

AT-007

CAS: 2170729-29-8

AT-007 is an investigational pharmaceutical compound, which is a small molecule inhibitor derived from advanced synthetic chemistry processes. It functions through the inhibition of aldose reductase, a key enzyme involved in the polyol pathway. By impeding this enzyme, AT-007 effectively reduces the accumulation of harmful sugar alcohols in cells, which otherwise contribute to cellular damage and the pathophysiology of certain metabolic disorders.

Fórmula: C₁₇H₁₀F₃N₃O₃S₂

Pureza: Min. 95%

Peso molecular: 425.4 g/mol

Ref: 3D-VLD72929